Approaches to prostatic 5 alpha-reductase inhibitors.
D015096:3-Hydroxysteroid Dehydrogenases / Q000378:metabolism; D058891:5-alpha Reductase Inhibitors; D000230:Adenocarcinoma / Q000201:enzymology; D000818:Animals; D002369:Castration; D004247:DNA / Q000378:metabolism; D007700:Kinetics; D008297:Male; D009374:Neoplasms, Experimental / Q000201:enzymology; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011467:Prostate / Q000201:enzymology* / Q000254:growth & development; D011471:Prostatic Neoplasms / Q000201:enzymology; D012313:RNA / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains
D058891:5-alpha Reductase Inhibitors; D012313:RNA; D004247:DNA; D010088:Oxidoreductases; D015096:3-Hydroxysteroid Dehydrogenases